VM Chart by TradingView

Business Description

Voyageur Pharmaceuticals Ltd., holder of three barium projects in B.C., including one with a resource estimate, and iodine properties in Utah, has a Joint Venture with privately held Chief Medical Supplies Ltd. (a Canadian pharmaceutical manufacturing and distribution company) to manufacture and market contrast agents (made with barium and/or iodine compounds) used for radiology digital imaging in the healthcare industry.

Website https://voyageurpharmaceuticals.ca/


FRC Analyst's Reports

Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company Jan. 7, 2020


News

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC – Video Available on Investmentpitch.com Jan. 13, 2022
IIROC Trading Resumption – VM Jan. 11, 2022
IIROC Trading Halt – VM Jan. 11, 2022
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Summit Nanotech to Develop Iodine Extraction Technology and Additions to Scientific Advisory Board – Video Available on Investmentpitch.com Nov. 9, 2021
Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians Oct. 18, 2021

This company was mentioned in the following "Analysts’ Ideas Of The Week":

Our Latest Top Pick is Up 61%
 Jan 17, 2022
All Eyes on Inflation Data This Week
 Aug 10, 2021
Highly Positive Data Supporting Vaccine Efficacy
 Aug 03, 2021
Last Week’s Pick Was Up 51% May 26, 2021
Is this a Signal for Consolidation in the Junior EV Metals Space? Apr 27, 2021
Rising Bond Yields to Lower Equity Valuations
 Feb 22, 2021
Caution Ahead as Copper Inventory Increases For the First Time in Six Weeks
 Dec 07, 2020
Rising M&A and Significant Cash on the Sidelines Positive for Juniors May 19, 2020